Literature DB >> 33950095

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?

Denise Rossato Silva1, Fernanda Carvalho de Queiroz Mello2, Lia D'Ambrosio3, Rosella Centis4, Margareth Pretti Dalcolmo5, Giovanni Battista Migliori3,4.   

Abstract

On April 1st, 2020, COVID-19 surpassed tuberculosis regarding the number of deaths per day worldwide. The combination of tuberculosis and COVID-19 has great potential for morbidity and mortality. In addition, the COVID-19 pandemic has had a significant impact on the diagnosis and treatment of tuberculosis. In this review article, we address concurrent tuberculosis and COVID-19, with particular regard to the differences between Brazil and Europe. In addition, we discuss priorities in clinical care, public health, and research.

Entities:  

Mesh：

Year:  2021        PMID： 33950095     DOI： 10.36416/1806-3756/e20210044

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


  6 in total

1.  Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives.

Authors:  Violina T Angelova; Tania Pencheva; Nikolay Vassilev; Elena K-Yovkova; Rositsa Mihaylova; Boris Petrov; Violeta Valcheva
Journal:  Antibiotics (Basel)       Date:  2022-04-22

2.  Tuberculosis forecasting and temporal trends by sex and age in a high endemic city in northeastern Brazil: where were we before the Covid-19 pandemic?

Authors:  Hamilton Leandro Pinto de Andrade; Dulce Gomes; Antônio Carlos Vieira Ramos; Luiz Henrique Arroyo; Marcelino Santos-Neto; Pedro Fredemir Palha; Regina Célia Fiorati; Inês Fronteira; Aline Aparecida Monroe; Márcio Souza Dos Santos; Miguel Fuentealba-Torres; Mellina Yamamura; Juliane de Almeida Crispim; Ricardo Alexandre Arcêncio
Journal:  BMC Infect Dis       Date:  2021-12-18       Impact factor: 3.090

3.  COVID-19 Related Hospital Re-organization and Trends in Tuberculosis Diagnosis and Admissions: Reflections From Portugal.

Authors:  Adelaide Alves; Ana Aguiar; Giovanni Battista Migliori; Raquel Duarte
Journal:  Arch Bronconeumol       Date:  2021-09-25       Impact factor: 6.333

Review 4.  Molecular and Cellular Mechanisms of M. tuberculosis and SARS-CoV-2 Infections-Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection.

Authors:  Anna A Starshinova; Igor Kudryavtsev; Anna Malkova; Ulia Zinchenko; Vadim Karev; Dmitry Kudlay; Angela Glushkova; Anastasiya Y Starshinova; Jose Dominguez; Raquel Villar-Hernández; Irina Dovgalyk; Piotr Yablonskiy
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

5.  Tuberculosis in Brazil: the impact of the COVID-19 pandemic.

Authors:  Célia Márcia Fernandes Maia; Daniella R Barbosa Martelli; Denise Maria Mendes L da Silveira; Eduardo Araújo Oliveira; Hercílio Martelli Júnior
Journal:  J Bras Pneumol       Date:  2022-04-20       Impact factor: 2.624

6.  Impact of COVID-19 on Tuberculosis Indicators in Brazil: A Time Series and Spatial Analysis Study.

Authors:  Thaís Zamboni Berra; Antônio Carlos Vieira Ramos; Yan Mathias Alves; Reginaldo Bazon Vaz Tavares; Ariela Fehr Tartaro; Murilo César do Nascimento; Heriederson Sávio Dias Moura; Felipe Mendes Delpino; Débora de Almeida Soares; Ruan Víctor Dos Santos Silva; Dulce Gomes; Aline Aparecida Monroe; Ricardo Alexandre Arcêncio
Journal:  Trop Med Infect Dis       Date:  2022-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.